499.8K XNAS Volume
XNAS 18 Mar, 2025 4:01 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Cintia Piccina | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,074,696 | 1,074,696 | - | - | Option to purchase Ordinary Shares | |
| William C. Bertrand | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,612,032 | 1,612,032 | - | - | Option to purchase Ordinary Shares | |
| William C. Bertrand | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,074,696 | 1,074,696 | - | - | Option to purchase Ordinary Shares | |
| Adrian Rawcliffe | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 5,143,248 | 5,143,248 | - | - | Option to purchase Ordinary Shares | |
| Adrian Rawcliffe | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 3,428,832 | 3,428,832 | - | - | Option to purchase Ordinary Shares | |
| John Lunger | Chief Patient Supply Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,612,032 | 1,612,032 | - | - | Option to purchase Ordinary Shares | |
| John Lunger | Chief Patient Supply Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,074,696 | 1,074,696 | - | - | Option to purchase Ordinary Shares | |
| Elliot Norry | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,612,032 | 1,612,032 | - | - | Option to purchase Ordinary Shares | |
| Elliot Norry | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,074,696 | 1,074,696 | - | - | Option to purchase Ordinary Shares | |
| Joanna Brewer | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,074,696 | 1,074,696 | - | - | Option to purchase Ordinary Shares | |
| Joanna Brewer | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,612,032 | 1,612,032 | - | - | Option to purchase Ordinary Shares | |
| Cintia Piccina | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,612,032 | 1,612,032 | - | - | Option to purchase Ordinary Shares | |
| Elliot Norry | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 17 Jan 2025 | 5,584 | 7,510 (0%) | 0% | 0.6 | 3,243 | American Depositary Shares representing Ordinary Shares |
| John Lunger | Chief Patient Supply Officer | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 17 Jan 2025 | 5,584 | 7,510 (0%) | 0% | 0.6 | 3,243 | American Depositary Shares representing Ordinary Shares |
| Adrian Rawcliffe | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 17 Jan 2025 | 30,601 | 44,327 (0%) | 0% | 0.6 | 17,773 | American Depositary Shares representing Ordinary Shares |
| William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 17 Jan 2025 | 5,584 | 7,510 (0%) | 0% | 0.6 | 3,243 | American Depositary Shares representing Ordinary Shares |
| Cintia Piccina | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.57 per share. | 15 Jan 2025 | 12,991 | 18,421 (0%) | 0% | 0.6 | 7,467 | American Depositary Shares representing Ordinary Shares |
| Elliot Norry | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 13 Jan 2025 | 8,124 | 11,516 (0%) | 0% | 0.6 | 4,776 | American Depositary Shares representing Ordinary Shares |
| William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.57 per share. | 13 Jan 2025 | 9,803 | 13,756 (0%) | 0% | 0.6 | 5,635 | American Depositary Shares representing Ordinary Shares |
| William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 13 Jan 2025 | 4,268 | 5,845 (0%) | 0% | 0.6 | 2,509 | American Depositary Shares representing Ordinary Shares |
| William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 13 Jan 2025 | 5,471 | 7,623 (0%) | 0% | 0.6 | 3,216 | American Depositary Shares representing Ordinary Shares |
| Adrian Rawcliffe | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.57 per share. | 13 Jan 2025 | 29,096 | 41,582 (0%) | 0% | 0.6 | 16,724 | American Depositary Shares representing Ordinary Shares |
| Adrian Rawcliffe | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 13 Jan 2025 | 12,539 | 17,801 (0%) | 0% | 0.6 | 7,372 | American Depositary Shares representing Ordinary Shares |
| Adrian Rawcliffe | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 13 Jan 2025 | 17,934 | 25,711 (0%) | 0% | 0.6 | 10,543 | American Depositary Shares representing Ordinary Shares |
| John Lunger | Chief Patient Supply Officer | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 13 Jan 2025 | 5,471 | 7,623 (0%) | 0% | 0.6 | 3,216 | American Depositary Shares representing Ordinary Shares |
| John Lunger | Chief Patient Supply Officer | Sale of securities on an exchange or to another person at price $ 0.57 per share. | 13 Jan 2025 | 9,803 | 13,756 (0%) | 0% | 0.6 | 5,635 | American Depositary Shares representing Ordinary Shares |
| John Lunger | Chief Patient Supply Officer | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 13 Jan 2025 | 4,268 | 5,845 (0%) | 0% | 0.6 | 2,509 | American Depositary Shares representing Ordinary Shares |
| Elliot Norry | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 13 Jan 2025 | 4,268 | 5,845 (0%) | 0% | 0.6 | 2,509 | American Depositary Shares representing Ordinary Shares |
| Elliot Norry | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.57 per share. | 13 Jan 2025 | 9,803 | 13,756 (0%) | 0% | 0.6 | 5,635 | American Depositary Shares representing Ordinary Shares |
| Priti Hegde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 1,144,686 | 1,144,686 | - | - | Option to purchase Ordinary Shares | |
| John P. Furey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 660,000 | 660,000 | - | - | Option to purchase Ordinary Shares | |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 1,144,686 | 1,144,686 | - | - | Option to purchase Ordinary Shares | |
| Garry E. Menzel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 1,121,604 | 1,121,604 | - | - | Option to purchase Ordinary Shares | |
| Lawrence M. Alleva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 1,213,926 | 1,213,926 | - | - | Option to purchase Ordinary Shares | |
| David M. Mott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 1,583,214 | 1,583,214 | - | - | Option to purchase Ordinary Shares | |
| Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 660,000 | 660,000 | - | - | Option to purchase Ordinary Shares | |
| Andrew R. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 660,000 | 660,000 | - | - | Option to purchase Ordinary Shares | |
| Cintia Piccina | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.93 per share. | 18 Jun 2024 | 24,531 | 38,293 (0%) | 0% | 0.9 | 22,814 | American Depositary Shares representing Ordinary Shares |
| Cintia Piccina | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 5,088,864 | 5,088,864 | - | - | Option to purchase Ordinary Shares | |
| Cintia Piccina | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 1,130,832 | 1,130,832 | - | - | Option to purchase Ordinary Shares | |
| John Lunger | Chief Patient Supply Officer | Sale of securities on an exchange or to another person at price $ 0.79 per share. | 16 Jan 2024 | 4,681 | 7,023 (0%) | 0% | 0.8 | 3,698 | American Depositary Shares representing Ordinary Shares |
| Elliot Norry | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 16 Jan 2024 | 12,967 | 19,257 (0%) | 0% | 0.7 | 8,727 | American Depositary Shares representing Ordinary Shares |
| Elliot Norry | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 16 Jan 2024 | 5,309 | 7,785 (0%) | 0% | 0.7 | 3,573 | American Depositary Shares representing Ordinary Shares |
| Elliot Norry | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.79 per share. | 16 Jan 2024 | 2,287 | 3,363 (0%) | 0% | 0.8 | 1,807 | American Depositary Shares representing Ordinary Shares |
| John Lunger | Chief Patient Supply Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 16 Jan 2024 | 5,309 | 7,785 (0%) | 0% | 0.7 | 3,573 | American Depositary Shares representing Ordinary Shares |
| John Lunger | Chief Patient Supply Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 16 Jan 2024 | 12,805 | 19,015 (0%) | 0% | 0.7 | 8,618 | American Depositary Shares representing Ordinary Shares |
| Adrian Rawcliffe | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 16 Jan 2024 | 30,080 | 44,848 (0%) | 0% | 0.7 | 20,244 | American Depositary Shares representing Ordinary Shares |
| Adrian Rawcliffe | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.79 per share. | 16 Jan 2024 | 9,304 | 14,104 (0%) | 0% | 0.8 | 7,350 | American Depositary Shares representing Ordinary Shares |
| William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.79 per share. | 16 Jan 2024 | 4,681 | 7,023 (0%) | 0% | 0.8 | 3,698 | American Depositary Shares representing Ordinary Shares |
| William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 16 Jan 2024 | 13,599 | 20,201 (0%) | 0% | 0.7 | 9,152 | American Depositary Shares representing Ordinary Shares |
| William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 16 Jan 2024 | 5,309 | 7,785 (0%) | 0% | 0.7 | 3,573 | American Depositary Shares representing Ordinary Shares |
| John Lunger | Chief Patient Supply Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 565,416 | 565,416 | - | - | Option to purchase Ordinary Shares | |
| Joanna Brewer | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 2,544,432 | 2,544,432 | - | - | Option to purchase Ordinary Shares | |
| Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 81,906 | 81,906 | - | - | Option to purchase Ordinary Shares | |
| William C. Bertrand | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 565,416 | 565,416 | - | - | Option to purchase Ordinary Shares | |
| William C. Bertrand | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 2,544,432 | 2,544,432 | - | - | Option to purchase Ordinary Shares | |
| Adrian Rawcliffe | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 1,696,272 | 1,696,272 | - | - | Option to purchase Ordinary Shares | |
| Joanna Brewer | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 565,416 | 565,416 | - | - | Option to purchase Ordinary Shares | |
| Elliot Norry | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 2,544,432 | 2,544,432 | - | - | Option to purchase Ordinary Shares | |
| Elliot Norry | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 565,416 | 565,416 | - | - | Option to purchase Ordinary Shares | |
| John Lunger | Chief Patient Supply Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 2,544,432 | 2,544,432 | - | - | Option to purchase Ordinary Shares | |
| Helen Tayton-Martin | Chief Business & Strgy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 565,416 | 565,416 | - | - | Option to purchase Ordinary Shares | |
| Helen Tayton-Martin | Chief Business & Strgy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 2,544,432 | 2,544,432 | - | - | Option to purchase Ordinary Shares | |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 40,950 | 40,950 | - | - | Option to purchase Ordinary Shares | |
| Gavin Hilary James Wood | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 565,416 | 565,416 | - | - | Option to purchase Ordinary Shares | |
| Gavin Hilary James Wood | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 2,544,432 | 2,544,432 | - | - | Option to purchase Ordinary Shares | |
| Adrian Rawcliffe | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 7,633,296 | 7,633,296 | - | - | Option to purchase Ordinary Shares | |
| Adrian Rawcliffe | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.84 per share. | 11 Jan 2024 | 11,945 | 18,395 (0%) | 0% | 0.8 | 9,994 | American Depositary Shares representing Ordinary Shares |
| Adrian Rawcliffe | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.85 per share. | 11 Jan 2024 | 17,257 | 26,388 (0%) | 0% | 0.9 | 14,739 | American Depositary Shares representing Ordinary Shares |
| John Lunger | Chief Patient Supply Officer | Sale of securities on an exchange or to another person at price $ 0.85 per share. | 11 Jan 2024 | 5,220 | 7,874 (0%) | 0% | 0.9 | 4,458 | American Depositary Shares representing Ordinary Shares |
| John Lunger | Chief Patient Supply Officer | Sale of securities on an exchange or to another person at price $ 0.84 per share. | 11 Jan 2024 | 4,009 | 6,104 (0%) | 0% | 0.8 | 3,354 | American Depositary Shares representing Ordinary Shares |
| William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.84 per share. | 11 Jan 2024 | 4,009 | 6,104 (0%) | 0% | 0.8 | 3,354 | American Depositary Shares representing Ordinary Shares |
| William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.85 per share. | 11 Jan 2024 | 5,220 | 7,874 (0%) | 0% | 0.9 | 4,458 | American Depositary Shares representing Ordinary Shares |
| Elliot Norry | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.84 per share. | 11 Jan 2024 | 4,009 | 6,104 (0%) | 0% | 0.8 | 3,354 | American Depositary Shares representing Ordinary Shares |
| Elliot Norry | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.85 per share. | 11 Jan 2024 | 7,799 | 11,841 (0%) | 0% | 0.9 | 6,661 | American Depositary Shares representing Ordinary Shares |